溃疡性-话题@MedSci

#溃疡性#

369篇内容 | 2327人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1695142, encodeId=629416951420e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=IBD：溃疡性结肠炎缓解期结肠上皮通透性和粘膜嗜酸性粒细胞增多, objectType=article, longId=186974, objectId=25031869e420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25031869e420, replyNumber=0, likeNumber=63, createdTime=2020-03-17, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25031869e420, moduleTitle=IBD：溃疡性结肠炎缓解期结肠上皮通透性和粘膜嗜酸性粒细胞增多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25031869e420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695206, encodeId=8732169520626, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=JCC: 与戒断治疗相比，缓解期溃疡性结肠炎患者继续使用抗TNF药物并不划算, objectType=article, longId=203628, objectId=8d2a203628b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d2a203628b7, replyNumber=0, likeNumber=0, createdTime=2021-05-17, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d2a203628b7, moduleTitle=JCC: 与戒断治疗相比，缓解期溃疡性结肠炎患者继续使用抗TNF药物并不划算, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d2a203628b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695160, encodeId=4a63169516000, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=IBD：克罗恩病和溃疡性结肠炎黏膜愈合时的戈利木单抗水平, objectType=article, longId=192152, objectId=277019215242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=277019215242, replyNumber=0, likeNumber=68, createdTime=2020-11-14, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=277019215242, moduleTitle=IBD：克罗恩病和溃疡性结肠炎黏膜愈合时的戈利木单抗水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=277019215242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695213, encodeId=395a1695213ce, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=Gastroenterology：SER-287（一种基于孢子的微生物组疗法）对活动性轻度至中度溃疡性结肠炎的安全性研究, objectType=article, longId=204728, objectId=0d8c204e28f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d8c204e28f3, replyNumber=0, likeNumber=22, createdTime=2020-12-29, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d8c204e28f3, moduleTitle=Gastroenterology：SER-287（一种基于孢子的微生物组疗法）对活动性轻度至中度溃疡性结肠炎的安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d8c204e28f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695200, encodeId=88b71695200e2, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=UEGW 2020：Etrolizumab治疗中重度溃疡性结肠炎，并不优于Infliximab（英夫利昔单抗）, objectType=article, longId=202070, objectId=15bb2020e093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15bb2020e093, replyNumber=0, likeNumber=69, createdTime=2020-11-23, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15bb2020e093, moduleTitle=UEGW 2020：Etrolizumab治疗中重度溃疡性结肠炎，并不优于Infliximab（英夫利昔单抗）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15bb2020e093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695138, encodeId=0aea169513819, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎, objectType=article, longId=186611, objectId=019918661107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=019918661107, replyNumber=0, likeNumber=46, createdTime=2020-03-13, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=019918661107, moduleTitle=美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=019918661107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695169, encodeId=4d92169516997, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=康方生物免疫治疗性抗体AK101获得溃疡性结肠炎临床试验批件, objectType=article, longId=194209, objectId=0c06194209e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c06194209e6, replyNumber=0, likeNumber=75, createdTime=2020-06-28, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c06194209e6, moduleTitle=康方生物免疫治疗性抗体AK101获得溃疡性结肠炎临床试验批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c06194209e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695141, encodeId=92ae169514139, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=口服溃疡性结肠炎新药Brilacidin的I期临床试验, objectType=article, longId=186742, objectId=dc09186e42b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc09186e42b5, replyNumber=0, likeNumber=107, createdTime=2020-06-30, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc09186e42b5, moduleTitle=口服溃疡性结肠炎新药Brilacidin的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc09186e42b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695182, encodeId=67cc1695182cf, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=etrolizumab治疗溃疡性结肠炎：III期结果并不乐观, objectType=article, longId=199178, objectId=e1f71991e85b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1f71991e85b, replyNumber=0, likeNumber=61, createdTime=2020-10-04, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1f71991e85b, moduleTitle=etrolizumab治疗溃疡性结肠炎：III期结果并不乐观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1f71991e85b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695152, encodeId=d135169515255, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=Clin Gastroenterology H：肿瘤坏死因子拮抗剂治疗难治性溃疡性直肠炎的疗效, objectType=article, longId=188661, objectId=f1ee18866149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ee18866149, replyNumber=0, likeNumber=63, createdTime=2020-08-04, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ee18866149, moduleTitle=Clin Gastroenterology H：肿瘤坏死因子拮抗剂治疗难治性溃疡性直肠炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ee18866149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695131, encodeId=b86c1695131c4, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=JCC：粪便钙卫蛋白可预测临床缓解期的溃疡性结肠炎的内镜和组织学疾病活动性, objectType=article, longId=185367, objectId=deb318536e1a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb318536e1a, replyNumber=0, likeNumber=59, createdTime=2020-04-09, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb318536e1a, moduleTitle=JCC：粪便钙卫蛋白可预测临床缓解期的溃疡性结肠炎的内镜和组织学疾病活动性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deb318536e1a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695202, encodeId=9eea1695202f0, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=Clin Gastroenterology H:普雷米司特（磷酸二酯酶-4的口服抑制剂）在活动性溃疡性结肠炎患者中的疗效分析, objectType=article, longId=202100, objectId=8c0120210016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c0120210016, replyNumber=0, likeNumber=71, createdTime=2021-06-26, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c0120210016, moduleTitle=Clin Gastroenterology H:普雷米司特（磷酸二酯酶-4的口服抑制剂）在活动性溃疡性结肠炎患者中的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c0120210016)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695162, encodeId=4612169516245, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=英国NICE推荐将IL-12/IL-23单抗ustekinumab，用于治疗活动性中度至重度溃疡性结肠炎, objectType=article, longId=193135, objectId=1689193135a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1689193135a7, replyNumber=0, likeNumber=0, createdTime=2020-06-16, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1689193135a7, moduleTitle=英国NICE推荐将IL-12/IL-23单抗ustekinumab，用于治疗活动性中度至重度溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1689193135a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695171, encodeId=4d6316951e155, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=英国NICE首次批准靶向IL-12/IL-23的单抗Stelara，用于治疗溃疡性结肠炎, objectType=article, longId=196065, objectId=c775196065fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c775196065fc, replyNumber=0, likeNumber=69, createdTime=2020-06-30, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c775196065fc, moduleTitle=英国NICE首次批准靶向IL-12/IL-23的单抗Stelara，用于治疗溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c775196065fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695139, encodeId=28d016951399d, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, objectType=article, longId=186637, objectId=713418663e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713418663e69, replyNumber=0, likeNumber=64, createdTime=2020-02-29, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713418663e69, moduleTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713418663e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695192, encodeId=7c06169519229, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=TAG:溃疡性结肠炎患者术前生物治疗对术后手术结局的影响, objectType=article, longId=201166, objectId=e614201166ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e614201166ef, replyNumber=0, likeNumber=65, createdTime=2021-04-17, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e614201166ef, moduleTitle=TAG:溃疡性结肠炎患者术前生物治疗对术后手术结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e614201166ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695185, encodeId=c8c416951859e, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=JCC: 克罗恩病患者和溃疡性结肠炎患者发生肠道腺癌的风险是一致的, objectType=article, longId=200014, objectId=2f90200014fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f90200014fd, replyNumber=0, likeNumber=71, createdTime=2020-12-27, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f90200014fd, moduleTitle=JCC: 克罗恩病患者和溃疡性结肠炎患者发生肠道腺癌的风险是一致的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f90200014fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695143, encodeId=17ac1695143e5, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=IBD：抗菌肽Cathelicidin可以介导维生素D在溃疡性结肠炎结肠上皮细胞中的保护作用, objectType=article, longId=186975, objectId=e9ff1869e5f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9ff1869e5f9, replyNumber=0, likeNumber=110, createdTime=2020-08-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9ff1869e5f9, moduleTitle=IBD：抗菌肽Cathelicidin可以介导维生素D在溃疡性结肠炎结肠上皮细胞中的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9ff1869e5f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695189, encodeId=58f9169518962, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=IBD: 女性溃疡性结肠炎患者初始手术类型对生育的影响, objectType=article, longId=200223, objectId=9a3e200223eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a3e200223eb, replyNumber=0, likeNumber=69, createdTime=2021-07-24, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a3e200223eb, moduleTitle=IBD: 女性溃疡性结肠炎患者初始手术类型对生育的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a3e200223eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1695153, encodeId=55fd1695153c0, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, objectTitle=AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性, objectType=article, longId=189026, objectId=b88d18902626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b88d18902626, replyNumber=0, likeNumber=109, createdTime=2020-09-30, rootId=0, userName=nymo, userId=787129789891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b88d18902626, moduleTitle=AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b88d18902626)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

溃疡性

2020-05-29

nymo (审核中...)

前往app查看评论内容

#溃疡性#

IBD：溃疡性结肠炎缓解期结肠上皮通透性和粘膜嗜酸性粒细胞增多

2020-03-17

nymo (审核中...)

前往app查看评论内容

#溃疡性#

JCC: 与戒断治疗相比，缓解期溃疡性结肠炎患者继续使用抗TNF药物并不划算

2021-05-17

nymo (审核中...)

前往app查看评论内容

#溃疡性#

IBD：克罗恩病和溃疡性结肠炎黏膜愈合时的戈利木单抗水平

2020-11-14

nymo (审核中...)

前往app查看评论内容

#溃疡性#

Gastroenterology：SER-287（一种基于孢子的微生物组疗法）对活动性轻度至中度溃疡性结肠炎的安全性研究

2020-12-29

nymo (审核中...)

前往app查看评论内容

#溃疡性#

UEGW 2020：Etrolizumab治疗中重度溃疡性结肠炎，并不优于Infliximab（英夫利昔单抗）

2020-11-23

nymo (审核中...)

前往app查看评论内容

#溃疡性#

美国FDA批准ABX464进行临床试验以治疗中重度溃疡性结肠炎

2020-03-13

nymo (审核中...)

前往app查看评论内容

#溃疡性#

康方生物免疫治疗性抗体AK101获得溃疡性结肠炎临床试验批件

2020-06-28

nymo (审核中...)

前往app查看评论内容

#溃疡性#

口服溃疡性结肠炎新药Brilacidin的I期临床试验

2020-06-30

nymo (审核中...)

前往app查看评论内容

#溃疡性#

etrolizumab治疗溃疡性结肠炎：III期结果并不乐观

2020-10-04

nymo (审核中...)

前往app查看评论内容

#溃疡性#

Clin Gastroenterology H：肿瘤坏死因子拮抗剂治疗难治性溃疡性直肠炎的疗效

2020-08-04

nymo (审核中...)

前往app查看评论内容

#溃疡性#

JCC：粪便钙卫蛋白可预测临床缓解期的溃疡性结肠炎的内镜和组织学疾病活动性

2020-04-09

nymo (审核中...)

前往app查看评论内容

#溃疡性#

Clin Gastroenterology H:普雷米司特（磷酸二酯酶-4的口服抑制剂）在活动性溃疡性结肠炎患者中的疗效分析

2021-06-26

nymo (审核中...)

前往app查看评论内容

#溃疡性#

英国NICE推荐将IL-12/IL-23单抗ustekinumab，用于治疗活动性中度至重度溃疡性结肠炎

2020-06-16

nymo (审核中...)

前往app查看评论内容

#溃疡性#

英国NICE首次批准靶向IL-12/IL-23的单抗Stelara，用于治疗溃疡性结肠炎

2020-06-30

nymo (审核中...)

前往app查看评论内容

#溃疡性#

J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究

2020-02-29

nymo (审核中...)

前往app查看评论内容

#溃疡性#

TAG:溃疡性结肠炎患者术前生物治疗对术后手术结局的影响

2021-04-17

nymo (审核中...)

前往app查看评论内容

#溃疡性#

JCC: 克罗恩病患者和溃疡性结肠炎患者发生肠道腺癌的风险是一致的

2020-12-27

zhouqu_8 (审核中...)

前往app查看评论内容

#溃疡性#

IBD：抗菌肽Cathelicidin可以介导维生素D在溃疡性结肠炎结肠上皮细胞中的保护作用

2020-08-08

nymo (审核中...)

前往app查看评论内容

#溃疡性#

IBD: 女性溃疡性结肠炎患者初始手术类型对生育的影响

2021-07-24

nymo (审核中...)

前往app查看评论内容

#溃疡性#

AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性

2020-09-30

科室
- - 订阅+
  - 更多科室
工具
服务